Ambery P, Parker VE, Stumvoll M, Posch MG, Heise T, Plum-Moerschel L, et al.MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
Real-time measurement of melanoma cell-mediated human brain endothelial barrier disruption using electric cell-substrate impedance sensing technology
C-Section Surgery Impact: The incision and healing process impact the core muscles, making it difficult for them to function properly
It is a direct blockade of one of the primary engines driving chronic inflammatory states
The Winter 2025 Optum Rx Drug Pipeline Insights Report highlights four innovative drugs that either have been approved or are expected to receive approval from the U.S